Skip to content

Clinical trials

Carcinoma trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Unknown status Country / region: China Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20123
20153
20162
20185
20193
20203
20215
20221
20236
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital4
First Hospital of Shijiazhuang City3
Fudan University2
Guangzhou Medical University2
Shanghai Yunying Medical Technology2
Xiaoxiang Chen2
Chinese PLA General Hospital1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
Multitude Therapeutics Inc.1
Peking University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma33
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Neoplasms7
Adenocarcinoma4
Neoplasms by Site4
Carcinoma, Ovarian Epithelial3
Colorectal Neoplasms3
Neoplasms by Histologic Type3
Neoplasms, Glandular and Epithelial3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.